OTOW Gains 63%

Recommended Stock Newsletters
 
#1. PennyStockWarfare
#2. Nova Stocks
#3. Penny Stock Finder


Shazamstocks Newsletter

Having trouble viewing this email Click here http://campaign.r20.constantcontact.com/renderca=1ebff918-565b-4eb8-aa67-11f885120968&c=caeeff60-3206-11e3-990f-d4ae529a8250&ch=cba3f780-3206-11e3-99aa-d4ae529a8250 O2 Secure Wireless, Inc. (OTOW) Gains 63% To.144 About O2 Secure Wireless (http://o2securewireless.com) O2 Secure Wireless is a Company that is currently developing numerous wireless tower facilities in the U.S. The Company is also instrumental in the development of wireless broadband communication services domestically. Under a merger with Earthcom Service Inc., the Company is currently being structured to provide affordable flat rate pre-paid wireless services in developing countries internationally StemCells Inc. (STEM) Gains 33 % To $ 2.09 StemCells says interim Phase I/II trial data show slowing of AMD progression StemCells reported interim results from its Phase I/II clinical trial of the company`s proprietary HuCNS-SC human neural stem cell platform in dry age-related macular degeneration, or AMD, yesterday evening at the 12th annual meeting of the International Society for Stem Cell Research in Vancouver, Canada. Interim trial results show a 65% reduction in the rate of geographic atrophy, or GA, in the study eye when compared to the expected natural history of the disease as well as a 70% reduction in the rate of GA when compared to the control eye. Stephen Huhn, chief medical officer at StemCells, said “The interim data are very encouraging from two separate perspectives. First, the reduction in the rate of geographic atrophy suggests the HuCNS-SC cells are affecting the underlying cause of AMD. Secondly, the data demonstrates there are increases in contrast sensitivity, which is a vital aspect of visual function.

Impacting the progression of GA and enhancing visual function could have a very meaningful impact on the quality of life for AMD patients and the results to date strongly support our plans to initiate a randomized, controlled, Phase II proof-of-concept trial later this year.” Swisher Hygiene Inc. (SWSH) Gains 18% To $4.15 Swisher Hygiene announced that the company received a letter from NASDAQ on June 17, noting the company has regained compliance with Listing Rule 5550(a)(2), which requires the company to maintain a minimum closing bid price of $1.00 per share.


NASDAQ staff made the determination after Swisher`s bid price closed above $1.00 per share for the prior 10 consecutive business days.

~~~~~~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~

Forward this email

 

No related posts.






You may also like...